Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Chronic Fatigue Syndrome: HELP
Articles from Karnataka
Based on 4 articles published since 2010
||||

These are the 4 published articles about Fatigue Syndrome, Chronic that originated from Karnataka during 2010-2020.
 
+ Citations + Abstracts
1 Review Temporomandibular disorders and functional somatic syndromes: deliberations for the dentist. 2012

Suma, S / Veerendra Kumar, B. ·Department of Oral and Maxillofacial Pathology, DA Pandu Memorial RV Dental College and Hospital, No. CA 37, 24th Main, JP Nagar I Phase, Bangalore, Karnataka, India. ·Indian J Dent Res · Pubmed #23257491.

ABSTRACT: Temporomandibular disorder (TMD) is an umbrella term for a collection of disorders affecting the temporomandibular joint (TMJ) and associated tissues. TMD is not a rare pathology for the dentist. The most common presenting symptom is pain, which causes the patient seek immediate treatment. Management is dictated by the cause. The most 'famed' causes include trauma, inflammation, aging, parafunctional habits, infections, neoplasms, and stress; and these are always considered in the differential diagnosis of TMJ pain. There are some less 'famed' causes of TMD, which are characterized by increased pain sensitivity due to psychosocial factors; these include myofascial pain syndrome and functional somatic syndromes (FSS) such as fibromyalgia and chronic fatigue syndrome. They present with chronic pain, fatigue, disability, and impairment in ability to perform daily activities. A non-systematic search in the English literature revealed numerous studies describing the occurrence of TMD in these conditions, along with few other oral manifestations. TMD has been even considered to be a part of the FSS by some. In these patients, TMD remains a recurring problem, and adequate management cannot be achieved by traditional treatment protocols. Awareness of these conditions, with correct diagnosis and modification of management protocols accordingly, may resolve this problem.

2 Article Amisulpride treatment of somatoform disorders: not just chronic fatigue. 2014

Goswami, Kausik / Saddichha, Sahoo / Chaturvedi, Santosh K. ·Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India. ·Am J Ther · Pubmed #23011165.

ABSTRACT: Amisulpride has been used to treat psychotic disorders and more recently even chronic fatigue. We describe 2 cases with somatoform disorders and who responded to low-dose amisulpride.

3 Article Evaluation of protective effect of Aegle marmelos Corr. in an animal model of chronic fatigue syndrome. 2012

Lalremruta, Vanphawng / Prasanna, Gurunath S. ·Department of Pharmacology, KLE University's College of Pharmacy, Rajajinagar, Bangalore, India. ·Indian J Pharmacol · Pubmed #22701245.

ABSTRACT: OBJECTIVE: To evaluate ethanolic extract of leaves of Aegle marmelos in an experimental animal model of chronic fatigue syndrome for potential therapeutic benefit. MATERIALS AND METHODS: Age/weight-matched female Wistar albino rats were grouped into five groups. (Group I- V) (n = 8). Group I served as naïve control and II served as stress control. Except for group I animals, other group animals were subjected to forced swimming every day for 15 minutes to induce a state of chronic fatigue and simultaneously treated with ethanolic extract of Aegle marmelos (EEAM) 150 and 250 mg/kg b.w. and Imipramine (20 mg.kg b.w.), respectively. Duration of immobility, anxiety level and locomotor activity were assessed on day 1, 7, 14 and 21 followed by biochemical estimation of oxidative biomarkers at the end of the study. RESULTS: Treatment with EEAM (150 and 250 mg/kg b.w.) resulted in a statistically significant and dose dependent reduction (P <0.001) in the duration of immobility, reduction in anxiety and increase in locomotor activity. Dose dependent and significant reduction in LPO level and increase in CAT and SOD was observed in extract treated animals. CONCLUSION: The results are suggestive of potential protective effect of A. marmelos against experimentally induced CFS.

4 Article Non-motor features in essential tremor. 2012

Chandran, V / Pal, P K / Reddy, J Y C / Thennarasu, K / Yadav, R / Shivashankar, N. ·Department of Neurology, National Institute of Mental Health & Neurosciences, Bangalore, India. ·Acta Neurol Scand · Pubmed #21777207.

ABSTRACT: INTRODUCTION: Essential tremor (ET) is increasingly recognized to have several non-motor manifestations. The aim of this study was to determine the prevalence of non-motor manifestations in ET and its impact on the quality of life (QOL). METHODS: This was a cross-sectional case-control questionnaire-based study. The subjects were 50 patients with ET and 50 matched healthy controls. All subjects were assessed by Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, Parkinson Fatigue Scale, Brief Pain Inventory, Hamilton Anxiety Rating Scale, and Hamilton Depression Rating Scale. In addition, QOL in Essential Tremor questionnaire was administered to patients with ET. RESULTS: Patients with ET, when compared with controls, had significantly higher prevalence and higher mean scores of sleep disturbances (46% vs 8%, P < 0.001; 5.9 ± 4.6 vs 2.6 ± 2.3, P < 0.001), fatigue (30% vs 8%, P = 0.009; 5.8 ± 0.8 vs 2.5 ± 0.4, P < 0.001), anxiety (66% vs 18%, P = 0.009; 7.4 ± 9.0 vs 0.7 ± 2.6, P < 0.001), depression (44% vs 8%, P = 0.009; 7.8 ± 7.9 vs 1.7 ± 3.3, P < 0.001) as well as higher mean score of pain severity (1.9 ± 2.3 vs 0.6 ± 1.2, P = 0.001) and interference owing to pain (2.0 ± 2.9 vs 0.5 ± 1.2, P = 0.001). Following hierarchical regression analysis, depression was the only non-motor feature that affected the QOL. CONCLUSION: There was a significantly higher prevalence and greater severity of sleep disturbances, fatigue, pain, anxiety, and depression in patients with ET and depression significantly affected the QOL.